PlasmaGen Biosciences funding, investors and company details

PlasmaGen Biosciences is an emerging Healthcare startup from Bengaluru, working in the space of Specializes exclusively in plasma protein therapies and speciality care products. Founded by Vivek V Kamath.

Company: PlasmaGen BioSciences Private Limited
Sector: Healthcare
Location: Bengaluru
Founders: Vivek V Kamath

Company overview

Plasmagen BioSciences specializes exclusively in plasma protein therapies and speciality care products, manufacturing human plasma-derived therapeutics such as immunoglobulins, albumin, and coagulation factors. The company bridges the gap in availability of these niche treatments by sourcing plasma through licensed blood banks, fractionating it in state-of-the-art facilities, and supplying to medical specialties including neurology, haematology, oncology, immunology, paediatrics, rheumatology, gynaecology, critical care, organ transplant, and dermatology. It focuses on enhancing affordability, accessibility, and safety via extensive audits, cold chain management, strategic partnerships for processing, and collaboration with government bodies on hemovigilance.

Funding rounds

Latest round: ₹150.00 Cr. ($ 16.49 Mn), 2025-12-23. Investors: ViNS Bioproducts
Past round: ₹225.00 Cr. ($ 27.05 Mn), 2023-12-15. Investors: Ashish Kacholia, Artian Investments